Stryker’s premier hammertoe treatment, Smart Toe II, pioneered the use of a one-piece, dynamic compression implant for hammertoe correction. Now with over 100,000 implants sold globally, Smart Toe II continues to provide demonstrated clinical outcomes.1,2
Smart Toe II animation
The Smart Toe II intramedullary implant was designed for correction of a hammertoe deformity. It offers rotational stability and compression across the joint line, while avoiding potential complications experienced with k-wires, such as pin tract infection and post-operative exposure. Smart Toe II has been clinically documented with fusion rates of over 90% and 2x the fusion rate of k-wires.
Smart Toe II hammertoe correction
This video shows a hammertoe correction, using a Smart Toe implant. It also shows a metatarsal shortening osteotomy, which is fixated with Fixos screws.
*According to a Medical Device reporting analysis performed in the Super and Trackwise systems for US reported events on August 3rd, 2015, the reported rate of implant failure for Smart Toe implant breakage between July 1, 2011 and August 3rd, 2015 was less than 1% of total Smart Toe implants sold.
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Smart Toe, Stryker.
All other trademarks are trademarks of their respective owners or holders.